RedHill Biopharma Ltd.
They are a specialty biopharmaceutical company, primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Last Closing Price
November 8, 2017
Cantor Fitzgerald, Nomura
To view the prospectus for RedHill Biopharma Ltd., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277